Purpose Cognitive impairment associated with human immunodeficiency virus (HIV)-related
cryptococcal meningitis (HCM) in the context of immune reconstitution inflammatory …

Cryptococcal meningitis (CM) is a common opportunistic infection in patients with acquired
immune deficiency syndrome. Although there is a standardized treatment for CM, some …

Background Patients with human immunodeficiency virus-associated cryptococcal
meningitis (HIV-CM) have persistent intracranial inflammation despite negative …

Background Although antiretroviral therapy (ART) improves survival in persons with
cryptococcal meningitis (CM) and AIDS, ART frequently elicits HIV immune reconstitution …

Background. Highly active antiretroviral therapy (HAART) has contributed to reducing the
occurrence of opportunistic infections and mortality in human immunodeficiency virus (HIV) …

Background: Prospective data on incidence, characteristics, and risk factors for cryptococcal
meningitis immune reconstitution inflammatory syndrome (CM-IRIS) are lacking. Methods …

Cryptococcal meningitis (CM) is an important opportunistic infection worldwide. After
initiation of highly active antiretroviral therapy (HAART), about 10%–20% of patients with …

Background Patients with human immunodeficiency virus/AIDS-associated cryptococcal
meningitis (CM) frequently experience clinical deterioration, known as cryptococcosis …

Background. The HIV-1 reservoir is a major barrier to curative strategies. Inflammation is an
important factor for HIV-1 reservoir persistence. Lenalidomide regulates inflammatory …

Objective: HIV-infected patients with treated cryptococcal meningitis are at risk for further
neurological deterioration after commencing combination antiretroviral therapy (cART) …